385 related articles for article (PubMed ID: 25708385)
1. Engagement of signaling pathways of protease-activated receptor 2 and μ-opioid receptor in bone cancer pain and morphine tolerance.
Bao Y; Gao Y; Hou W; Yang L; Kong X; Zheng H; Li C; Hua B
Int J Cancer; 2015 Sep; 137(6):1475-83. PubMed ID: 25708385
[TBL] [Abstract][Full Text] [Related]
2. Blocking mammalian target of rapamycin alleviates bone cancer pain and morphine tolerance via µ-opioid receptor.
Jiang Z; Wu S; Wu X; Zhong J; Lv A; Jiao J; Chen Z
Int J Cancer; 2016 Apr; 138(8):2013-20. PubMed ID: 26566757
[TBL] [Abstract][Full Text] [Related]
3. Blocking PAR2 attenuates oxaliplatin-induced neuropathic pain via TRPV1 and releases of substance P and CGRP in superficial dorsal horn of spinal cord.
Chen K; Zhang ZF; Liao MF; Yao WL; Wang J; Wang XR
J Neurol Sci; 2015 May; 352(1-2):62-7. PubMed ID: 25829079
[TBL] [Abstract][Full Text] [Related]
4. Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain.
Chen Y; Yang C; Wang ZJ
Neuroscience; 2011 Oct; 193():440-51. PubMed ID: 21763756
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsilon- and A-dependent mechanisms in rats and mice.
Amadesi S; Cottrell GS; Divino L; Chapman K; Grady EF; Bautista F; Karanjia R; Barajas-Lopez C; Vanner S; Vergnolle N; Bunnett NW
J Physiol; 2006 Sep; 575(Pt 2):555-71. PubMed ID: 16793902
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence.
Bao Y; Gao Y; Yang L; Kong X; Yu J; Hou W; Hua B
Channels (Austin); 2015; 9(5):235-43. PubMed ID: 26176938
[TBL] [Abstract][Full Text] [Related]
7. Involvement of protease-activated receptor 2 in nociceptive behavior in a rat model of bone cancer.
Bao Y; Hua B; Hou W; Shi Z; Li W; Li C; Chen C; Liu R; Qin Y
J Mol Neurosci; 2014 Apr; 52(4):566-76. PubMed ID: 24057889
[TBL] [Abstract][Full Text] [Related]
8. Resistance to morphine analgesic tolerance in rats with deleted transient receptor potential vanilloid type 1-expressing sensory neurons.
Chen SR; Prunean A; Pan HM; Welker KL; Pan HL
Neuroscience; 2007 Mar; 145(2):676-85. PubMed ID: 17239544
[TBL] [Abstract][Full Text] [Related]
9. Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats.
Zhang M; Wang K; Ma M; Tian S; Wei N; Wang G
Anesth Analg; 2016 Apr; 122(4):1031-7. PubMed ID: 26720619
[TBL] [Abstract][Full Text] [Related]
10. PAR2-mediated upregulation of BDNF contributes to central sensitization in bone cancer pain.
Bao Y; Hou W; Liu R; Gao Y; Kong X; Yang L; Shi Z; Li W; Zheng H; Jiang S; Li C; Qin Y; Hua B
Mol Pain; 2014 May; 10():28. PubMed ID: 24886294
[TBL] [Abstract][Full Text] [Related]
11. Hypersensitivity Induced by Activation of Spinal Cord PAR2 Receptors Is Partially Mediated by TRPV1 Receptors.
Mrozkova P; Spicarova D; Palecek J
PLoS One; 2016; 11(10):e0163991. PubMed ID: 27755539
[TBL] [Abstract][Full Text] [Related]
12. Contributions of spinal D-amino acid oxidase to bone cancer pain.
Huang JL; Chen XL; Guo C; Wang YX
Amino Acids; 2012 Nov; 43(5):1905-18. PubMed ID: 22996731
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of PAR2 and TRPA1 signals alleviates neuropathic pain evoked by chemotherapeutic bortezomib.
Wang Q; Wang J; Gao D; Li J
J Biol Regul Homeost Agents; 2017; 31(4):977-983. PubMed ID: 29254302
[TBL] [Abstract][Full Text] [Related]
14. Role of endogenous melatoninergic system in development of hyperalgesia and tolerance induced by chronic morphine administration in rats.
Fan Y; Liang X; Wang R; Song L
Brain Res Bull; 2017 Oct; 135():105-112. PubMed ID: 28988976
[TBL] [Abstract][Full Text] [Related]
15. The pain pathway in the rat following noxious thermal stimulation: effect of morphine on pERK1/2 and TRPV1 at the dorsal horn level, and on hyperalgesia.
Donnerer J; Liebmann I
Pharmacology; 2013; 92(1-2):32-8. PubMed ID: 23880531
[TBL] [Abstract][Full Text] [Related]
16. Blocking EphB1 receptor forward signaling in spinal cord relieves bone cancer pain and rescues analgesic effect of morphine treatment in rodents.
Liu S; Liu WT; Liu YP; Dong HL; Henkemeyer M; Xiong LZ; Song XJ
Cancer Res; 2011 Jul; 71(13):4392-402. PubMed ID: 21555368
[TBL] [Abstract][Full Text] [Related]
17. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
18. The mu opioid agonist morphine modulates potentiation of capsaicin-evoked TRPV1 responses through a cyclic AMP-dependent protein kinase A pathway.
Vetter I; Wyse BD; Monteith GR; Roberts-Thomson SJ; Cabot PJ
Mol Pain; 2006 Jul; 2():22. PubMed ID: 16842630
[TBL] [Abstract][Full Text] [Related]
19. Spinal PAR2 Activation Contributes to Hypersensitivity Induced by Peripheral Inflammation in Rats.
Mrozkova P; Spicarova D; Palecek J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498178
[TBL] [Abstract][Full Text] [Related]
20. Enhanced function of TRPV1 via up-regulation by insulin-like growth factor-1 in a rat model of bone cancer pain.
Li Y; Cai J; Han Y; Xiao X; Meng XL; Su L; Liu FY; Xing GG; Wan Y
Eur J Pain; 2014 Jul; 18(6):774-84. PubMed ID: 24827675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
